Kura Oncology (KURA) Profit Metrics
Price: $6.38
Market Cap: $514.81M
Avg Volume: 1.46M
Market Cap: $514.81M
Avg Volume: 1.46M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Profit Metrics Summary (Annual)
According to Kura Oncology's latest annual financial reports:
- The company has reported a gross profit of 53.88M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 100.00%, with a year-over-year growth of 6446.64%.
- Kura Oncology's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -169.50M. The EBITDA margin stands at -314.57%, showing a growth of -2.75% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at -193.19M. The operating margin is -358.55%, with a year-over-year growth of -16.52%.
- The net income, which shows the company's total earnings or profit after all expenses, is -173.98M. The net profit margin is -322.89%, demonstrating a growth of -13.99% from the previous year.
These metrics provide a comprehensive overview of Kura Oncology's profitability and operational efficiency over the past year.
Gross Profit
$53.88M
Gross Profit Margin (2023)
100.00%
EBITDA
$-169.50M
EBITDA Margin
-314.57%
Operating Income (2023)
$-193.19M
Operating Margin
-358.55%
Net Income
$-173.98M
Net Profit Margin
-322.89%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
Kura Oncology Historical Profit Metrics
Kura Oncology Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $53.88M | 6446.64% | $-193.19M | -16.52% | $-173.98M | -13.99% | $-169.50M | -2.75% |
| 2023 | $-849.00K | -11.86% | $-165.80M | -17.91% | $-152.63M | -12.17% | $-164.96M | -18.58% |
| 2022 | $-759.00K | -36.02% | $-140.62M | -6.68% | $-136.07M | -4.74% | $-139.11M | -7.25% |
| 2021 | $-558.00K | -187.63% | $-131.82M | -43.13% | $-129.91M | -45.26% | $-129.71M | -41.44% |
| 2020 | $-194.00K | 0.00% | $-92.09M | -36.48% | $-89.43M | -41.64% | $-91.70M | -35.90% |
| 2019 | $- | 100.00% | $-67.48M | -7.31% | $-63.14M | -4.46% | $-67.48M | -7.33% |
| 2018 | $-10.00K | 66.67% | $-62.88M | -74.30% | $-60.45M | -70.59% | $-62.87M | -74.42% |
| 2017 | $-30.00K | 3.23% | $-36.08M | -27.18% | $-35.43M | -28.57% | $-36.05M | -27.21% |
| 2016 | $-31.00K | -55.00% | $-28.37M | -18.86% | $-27.56M | -21.81% | $-28.34M | -18.83% |
| 2015 | $-20.00K | 16.34% | $-23.86M | -102.21% | $-22.62M | -105.44% | $-23.84M | -102.09% |
| 2014 | $-23.91K | -5.16% | $-11.80M | -52726.64% | $-11.01M | -40218.51% | $-11.80M | -52713.21% |
| 2013 | $-22.73K | -1.76% | $-22.34K | 4.69% | $-27.32K | -1.02% | $-22.34K | 4.69% |
| 2012 | $-22.34K | 4.69% | $-23.44K | -14.29% | $-27.04K | -20.74% | $-23.44K | -14.29% |
| 2011 | $-23.44K | -14.29% | $-20.51K | 50.00% | $-22.39K | 0.00% | $-20.51K | 50.00% |
| 2010 | $-20.51K | -7.05% | $-41.02K | -7.05% | $-22.39K | -12.00% | $-41.02K | -7.05% |
| 2009 | $-19.16K | 0.00% | $-38.32K | -13.96% | $-20.00K | 40.53% | $-38.32K | -13.96% |
| 2008 | $- | 0.00% | $-33.62K | 0.00% | $-33.62K | 0.00% | $-33.62K | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for KURA.